New EMDR Research: Key Studies From 2024 to 2026

Between 2024 and 2026, EMDR research delivered new large meta-analyses for PTSD, depression, and children, a 2025 APA guideline update that reignited debate over EMDR’s rating without actually changing it, telehealth and virtual-reality trials, and the first published brain-imaging study of a self-administered technique. No study yet has tested a fully unsupervised app for PTSD.

EMDR research doesn’t sit still, and the past two years moved more than most. This page rounds up what’s genuinely new since 2024: not a repeat of the older meta-analyses everyone already cites, but the studies, guideline changes, and open disagreements that landed in this specific window. Every claim below names its source and sample size, so you can judge each finding’s strength yourself.

What’s new in EMDR research at a glance?

• Three major meta-analyses landed within about 18 months of each other: Wright et al. (2024) on PTSD, Simpson et al. (2025) on adult PTSD cost-effectiveness, and Villegas-Ortega et al. (2026) on EMDR versus waitlist.
• The APA updated its PTSD guideline in mid-2025 without moving EMDR’s own “conditional recommendation” tier, which hasn’t changed since 2017; a 2025 critique argues that tier still underrates EMDR next to other national and international guidelines.
• A 2025 multisite review of 279 veterans found telehealth and in-person EMDR produced similarly large gains; a 2025 trial protocol is now testing remote EMDR for parents of medically ill children.
• A 2025 randomized trial tested virtual-reality EMDR for depression tied to childhood trauma; a 159-patient trial in JAMA Network Open tested EMDR for personality disorders more broadly.
• The first fMRI study of a self-administered bilateral-stimulation technique, the butterfly hug, appeared in 2025, alongside a separate study measuring its effect on heart-rate variability.
• A 2025 pilot trial tested a four-app EMDR-based series against a waitlist, still the only app-specific trial to exist.
• Across all of it: no study from 2024 to 2026 tested a fully unsupervised, self-guided app against a diagnosed condition.

What did the newest meta-analyses find?

Five pooled analyses published between 2024 and 2026 add fresh weight to the older evidence, without overturning it.

Year	Meta-analysis	What it studied	Headline finding
2024	Wright et al.	Individual-participant data across trauma-focused therapies	No significant difference between EMDR and other trauma-focused therapies for PTSD
2024	Seok & Kim	25 trials, 1,042 people, EMDR for depression	Significant drop in depression symptoms (Hedges’s g = 0.75), larger in more severe cases
2025	Simpson et al.	16 trials, 1,031 adults with PTSD	Matched trauma-focused CBT, with shorter treatment and lower dropout; modeling found it the most cost-effective option studied
2025	Sutton et al.	8 RCTs, 794 children and teens	Helped versus waitlist or usual care; ranked 6th of 10 interventions on limited cost-effectiveness data
2026	Villegas-Ortega et al.	12 trials, 690 adults with PTSD	About twice as likely to lose a PTSD diagnosis versus waitlist (low-certainty evidence)

Read together, these five span PTSD, depression, and children specifically, and none of them overturns the older picture: EMDR still looks comparable to trauma-focused CBT for PTSD, with softer, newer evidence outside it. What changed is the pace. Three of these five arrived within about eighteen months of each other, more concentrated pooling than most three-year stretches in EMDR’s history. For the full 35-year arc these five slot into, see EMDR meta-analyses; for the underlying PTSD evidence itself, see EMDR and PTSD.

Why did the 2025 APA guideline update spark pushback?

In mid-2025, the American Psychological Association released an updated Clinical Practice Guideline for PTSD in adults. Headlines calling it a downgrade for EMDR get the story backward. EMDR has held a “conditionally recommended” rating since the guideline’s original 2017 version, one tier below its “strong recommendation” tier. The 2025 update didn’t move EMDR at all. What changed is that cognitive therapy dropped out of the strong tier and joined EMDR’s conditional one. Cognitive Processing Therapy, Prolonged Exposure, and trauma-focused CBT now anchor the top tier by name. Our full breakdown of the APA’s EMDR rating covers the 2017-to-2025 shift tier by tier.

That conditional placement hasn’t sat quietly, in 2017 or in 2025. A 2025 critique in the Journal of EMDR Practice and Research argues the panel applied a stricter evidence bar to EMDR than other guideline bodies have applied to the same trials, and that the rating still undersells EMDR’s real-world effectiveness.

Neither side has the final word. What’s genuinely new since 2024 is that this old disagreement resurfaced. The WHO, VA/DoD, and NICE positions covered in our guideline roundup still rank EMDR closer to their top tier than the APA does, and the pushback arrived quickly once the 2025 update published. That’s a live disagreement worth watching, not a new downgrade: EMDR’s own tier was never downgraded to begin with.

What do new studies show about telehealth and remote EMDR?

Two 2025 studies looked at EMDR delivered at a distance. A multisite retrospective review of 279 veterans, 139 treated in person and 140 by telehealth, found both groups improved substantially on PTSD and depression measures. In-person care showed a somewhat larger effect on PTSD specifically after adjusting for other factors, but completion rates were similar either way.

A second 2025 study, published as a trial protocol in BMC Psychology, hasn’t reported results yet. It’s testing brief remote EMDR against brief in-person EMDR and a waitlist, for parents whose children have chronic or acute medical conditions, a group that’s rarely offered trauma treatment at all. The trial itself is the notable part: researchers now consider remote delivery worth testing head-to-head, even in populations EMDR research has barely touched before.

What’s new in EMDR technology and other conditions?

Virtual reality made an appearance too. A 2025 randomized trial gave 72 adults with major depressive disorder and childhood trauma either 12 sessions of VR-based EMDR or a waitlist spot. The VR group improved more on depression, traumatic-experience measures, and cognitive performance, with some gains still present three months later. It’s one early trial, not a green light for VR headsets as treatment.

New research also pushed into conditions further from EMDR’s usual focus. A 159-patient trial in JAMA Network Open found EMDR beat a waitlist control for personality disorders more broadly, not just the PTSD symptoms that sometimes accompany them, with 44% of the EMDR group in remission at follow-up. That’s a considerably larger, more rigorous design than most single studies in this space.

What has new brain and body research found?

Two 2025 studies looked at what bilateral stimulation does physiologically. An fMRI study of women with cancer-related PTSD used the butterfly hug, a self-administered tapping technique, as the bilateral-stimulation method inside a structured EMDR protocol. It found measurable activity changes in the amygdala, hippocampus, and prefrontal cortex, the regions most tied to the traumatic-stress response. It’s notable partly because it studied a self-administered technique specifically, not therapist-directed eye movements.

Separately, a 2025 study in BJPsych Open found that brief bilateral stimulation raised heart rate variability, a marker of a calmer nervous system, in both people with PTSD and healthy volunteers with no trauma history. Our deeper look at how bilateral stimulation affects your nervous system covers this mechanism research in full.

Has research on self-guided or app-based EMDR grown?

Barely, but it didn’t stay at zero. A 2025 pilot randomized trial tested a four-app EMDR-based series against a waitlist in 77 adults with chronic PTSD and pain. The app group’s PTSD symptoms improved more, though the app’s developer co-authored the study and dropout was high enough that the researchers called for a larger, independent follow-up before drawing firm conclusions.

That’s still the only app-specific trial to exist. No study from 2024 to 2026 tested a fully unsupervised app against a diagnosed condition with a rigorous design, and EMDRIA, EMDR’s professional association, continues to say the therapy should only be offered by a trained, licensed clinician. Our full breakdown of self-administered EMDR research goes deeper on what this thin evidence base does and doesn’t support.

What does this new research mean if you practice bilateral stimulation on your own?

None of the studies above tested self-guided practice for everyday stress, which is a separate, more modest use than any diagnosed condition they studied. If you want to try bilateral stimulation yourself, the same three guardrails apply no matter what’s newest in the research.

Stabilize first. Spend a few minutes settling, slow breathing, feet on the floor, before bringing anything uncomfortable to mind.

Go slow. Start with one small, recent, low-intensity target, not a defining memory, and keep sessions short.

Know your stop-conditions. If distress climbs past a 7 out of 10 and won’t settle, stop and ground yourself instead; consider working with a professional if that keeps happening. If thoughts of harming yourself surface, visit our crisis resources page or call or text 988 (US) first.

EmEase, a self-guided EMDR app, stays inside that boundary deliberately: guided visual and audio bilateral stimulation for practicing the technique on your own time, for everyday stress rather than the diagnosed conditions the studies above tested.

The bottom line

Two years produced real movement: new meta-analyses across three conditions, a contested guideline change, new delivery formats, and the first brain-imaging look at a self-administered technique. None of it changes the oldest caveat on this site: every trial above tested therapist-delivered or app-assisted care for a diagnosed condition, not solo practice for everyday stress. For the fuller history behind these newest findings, see EMDR meta-analyses; for the basics, start with does EMDR work?